SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-012856
Filing Date
2022-03-30
Accepted
2022-03-30 20:32:10
Documents
1
Period of Report
2022-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4338
  Complete submission text file 0000899243-22-012856.txt   5725
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472
Business Address
Wanstall Rick (Reporting) CIK: 0001771222 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38130 | Film No.: 22788673